Nomura Research Institute Ltd
OTC:NURAF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nomura Research Institute Ltd
OTC:NURAF
|
JP |
|
D
|
Dexcom Inc
XMUN:DC4
|
US |
|
D
|
Daicel Corp
OTC:DACHF
|
JP |
|
V
|
Vocento SA
SWB:VON
|
ES |
|
Viva Energy Group Ltd
ASX:VEA
|
AU |
|
Pfizer Ltd
NSE:PFIZER
|
IN |
|
U
|
United States Steel Corp
XHAM:USX1
|
US |
|
A
|
Aemulus Holdings Bhd
KLSE:AEMULUS
|
MY |
Wall St Price Targets
NURAF Price Targets Summary
Nomura Research Institute Ltd
According to Wall Street analysts, the average 1-year price target for NURAF is 40.17 USD with a low forecast of 34.69 USD and a high forecast of 48.33 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NURAF's stock price target?
Price Target
40.17
USD
According to Wall Street analysts, the average 1-year price target for NURAF is 40.17 USD with a low forecast of 34.69 USD and a high forecast of 48.33 USD.
What is the Revenue forecast for Nomura Research Institute Ltd?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Nomura Research Institute Ltd?
Projected CAGR
116%
Over the last 14 years, the compound annual growth rate for Net Income has been -5%. The projected CAGR for the next 3 years is 116%.
